Sign In
Buy MMEDF
$1.09
+0 (+0%)
At Close: Aug 17, 2022
MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
01:48pm, Friday, 26'th Feb 2021
Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Karlin and former Google AI/ML industry veteran Br
8 Risky Stocks to Buy If Danger Is Your Middle Name
09:20am, Wednesday, 24'th Feb 2021
With the market at incredibly frothy valuations, buying into speculative ventures isn't for everyone. Still, if you can handle the potential volatility, these risky stocks to buy may have more room to
MindMed to acquire AI medicine company HealthMode in cash and stock deal
09:46am, Thursday, 18'th Feb 2021
Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ) announced a cash-and-stock deal to acquire HealthMode, a digital medicine and therapeutics start-up that uses Artificial Intelligence (AI
Psyched: MindMed Enters Psychedelics 2.0, Mind Cure Raises $18M, Mydecine Raises $13M
11:44am, Wednesday, 17'th Feb 2021
Mind Cure Health Inc. (CSE:MCUR) recently announced the closing of a CA$23 Million ($18.1 million) offering. The company issued approximately 38 million units, consisting of one share and one half of
MindMed launches Phase 1 study of potential LSD 'emergency off-switch' ketanserin
09:52am, Wednesday, 17'th Feb 2021
Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ) announced Wednesday the start of a Phase 1 study for its LSD neutralizer technology, which is designed to shorten and stop the effects of
MindMed seeks to harvest the power of psychedelics to treat mental health disorders
12:35pm, Friday, 12'th Feb 2021
Develops psychedelic medicines to improve health, promote wellness and alleviate suffering Working with LSD, DMT, 18-MC, and MDMA as possible therapies for anxiety, addiction, cluster headaches, a
MMEDF Stock: Why Psychedelics Play MindMed Is Feeling Groovy Today
01:28pm, Thursday, 11'th Feb 2021
MindMed (MMEDF) stock is heading higher on Thursday following news of a partnership deal with Swiss startup MindShift Compounds AG. The post MMEDF Stock: Why Psychedelics Play MindMed Is Feeling Groov
MindMed strikes partnership with Swiss startup MindShift Compounds to develop and patent next-gen psychedelic compounds
10:07am, Thursday, 11'th Feb 2021
Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ) announced Thursday a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with
8 Cheap Stocks Under $20 That Could Double
09:05am, Thursday, 11'th Feb 2021
Even though the market has been on fire recently, that doesn't mean you're too late to pick up cheap stocks under $20 with 2x (or more) potential. The post 8 Cheap Stocks Under $20 That Could Double a
The Best Stocks to Buy in the Market Today, According to Jeff Bezos
12:07pm, Thursday, 04'th Feb 2021
The world's biggest companies -- and the market's best stocks to buy -- all have one thing in common: They're relentlessly innovative. The post The Best Stocks to Buy in the Market Today, According
Short-Squeeze Stocks Are a Great Way to Score 10X Gains. Here's a Better Way
02:31pm, Wednesday, 27'th Jan 2021
GME stock's meteoric rise is proof that short squeeze stocks are a great way to score 10X gains. But we have an even better way.
9 Stocks Selling at a Discount Right Now
09:11am, Tuesday, 26'th Jan 2021
One of the surprising developments of 2020 was the tremendous rise of the equities market. However, there are still undervalued opportunities to be had with these stocks selling at a discount.
MMEDF Stock Alert: Why Psychedelics Leader MindMed Is Climbing Today
03:54pm, Wednesday, 20'th Jan 2021
MMEDF stock is on the move today after psychedelics firm MindMed announced a new clinical trial. Here's what you should know.
MindMed Begins First-Ever Clinical Trial On MDMA, LSD Combinations
09:11am, Wednesday, 20'th Jan 2021
Mind Medicine (MindMed) Inc (OTC: MMEDF), a medicine biotech company in psychedelics, on Wednesday announced its start of the first-ever clinical trial measuring and evaluating 3,4-methylenedioxymeth
MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD
07:30am, Wednesday, 20'th Jan 2021
BASEL, Switzerland, Jan. 20, 2021 /PRNewswire/ -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, announced today the start of the first ever clinical t
